|
| 36854952 | A review of economic issues for gene-targeted therapies: Value, affordability, and access. | Am J Med Genet C Semin Med Genet | 2023 |
| 38065071 | Genomic medicine year in review: 2023. | Am J Hum Genet | 2023 |
| 37435610 | Payer reimbursement practices and incentives for improving interpretation of germline genetic testing. | J Law Biosci | 2023 |
| 35254936 | Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access. | Health Aff (Millwood) | 2022 |
| 35485600 | A research agenda to support the development and implementation of genomics-based clinical informatics tools and resources. | J Am Med Inform Assoc | 2022 |
| 36459977 | Genomic Medicine Year in Review: 2022. | Am J Hum Genet | 2022 |
| 34222015 | Association of Breast Cancer Screening Behaviors With Stage at Breast Cancer Diagnosis and Potential for Additive Multi-Cancer Detection <i>via</i> Liquid Biopsy Screening: A Claims-Based Study. | Front Oncol | 2021 |
| 34861172 | Genomic medicine year in review: 2021. | Am J Hum Genet | 2021 |
| 32389218 | Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions. | Value Health | 2020 |
| 33275910 | Genomic Medicine Year in Review: 2020. | Am J Hum Genet | 2020 |
| 32715662 | Genetic testing and employer-sponsored wellness programs: An overview of current vendors, products, and practices. | Mol Genet Genomic Med | 2020 |
| 30994069 | Characterizing the Biomedical Data-Sharing Landscape. | J Law Med Ethics | 2019 |
| 32027834 | Genomic Medicine Year in Review: 2019. | Am J Hum Genet | 2019 |
| 31395439 | Opportunities, resources, and techniques for implementing genomics in clinical care. | Lancet | 2019 |
| 30994075 | The Role of Participants in a Medical Information Commons. | J Law Med Ethics | 2019 |
| 30994071 | Hopeful and Concerned: Public Input on Building a Trustworthy Medical Information Commons. | J Law Med Ethics | 2019 |
| 29733704 | Genetic Test Availability And Spending: Where Are We Now? Where Are We Going? | Health Aff (Millwood) | 2018 |
| 30224106 | Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions. | Value Health | 2018 |
| 29674586 | Insurance coverage for genomic tests. | Science | 2018 |
| 29460415 | Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects. | Clin Pharmacol Ther | 2018 |
| 29684151 | A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies. | J Natl Cancer Inst | 2018 |
| 27657682 | Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening. | Genet Med | 2017 |
| 28406488 | Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research. | Genet Med | 2017 |
| 28188191 | Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative. | J Natl Compr Canc Netw | 2017 |
| 28212967 | Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies. | Value Health | 2017 |
| 28938910 | Creating a data resource: what will it take to build a medical information commons? | Genome Med | 2017 |
| 29065945 | EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS. | Int J Technol Assess Health Care | 2017 |
| 28700544 | Payer coverage policies for multigene tests. | Nat Biotechnol | 2017 |
| 27668172 | Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel. | Appl Transl Genom | 2016 |
| 26633547 | Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncology. | Genet Med | 2016 |
| 25274556 | Comparative effectiveness research and demonstrating clinical utility for molecular diagnostic tests. | Clin Chem | 2015 |
| 24634466 | Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer. | Clin Cancer Res | 2014 |
| 25298289 | Clinical integration of next generation sequencing: coverage and reimbursement challenges. | J Law Med Ethics | 2014 |
| 25387182 | Overcoming the reimbursement barriers for clinical sequencing. | JAMA | 2014 |
| 25399713 | Useless until proven effective: the clinical utility of preemptive pharmacogenetic testing. | Clin Pharmacol Ther | 2014 |
| 23037935 | Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research. | Genet Med | 2013 |
| 23635833 | Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. | Med Decis Making | 2013 |
| 23000081 | Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes. | Contemp Clin Trials | 2013 |
| 22274803 | Prioritization in comparative effectiveness research: the CANCERGEN Experience. | Med Care | 2012 |
| 24236417 | Stakeholder engagement in comparative effectiveness research: how will we measure success? | J Comp Eff Res | 2012 |
| 23459832 | Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process. | J Comp Eff Res | 2012 |
| 22707880 | Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement. | J Comp Eff Res | 2012 |
| 22481130 | Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. | Genet Med | 2012 |
| 19407441 | Factors influencing uptake of pharmacogenetic testing in a diverse patient population. | Public Health Genomics | 2010 |
| 20055709 | Economic opportunities and challenges for pharmacogenomics. | Annu Rev Pharmacol Toxicol | 2010 |
| 20017668 | Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care. | Pharmacogenomics | 2010 |
| 19204417 | Pharmacogenomics, evidence, and the role of payers. | Public Health Genomics | 2009 |
| 18679180 | Harnessing economic drivers for successful clinical implementation of pharmacogenetic testing. | Clin Pharmacol Ther | 2008 |
| 17351847 | Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions. | J Gen Intern Med | 2007 |
| 18694212 | Determining user preferences between touch and pen data entry methods in the Tablet PC computing environment. | AMIA Annu Symp Proc | 2007 |